David Brennan News
-
A U.K. pension group recommended that members vote against drugmaker AstraZeneca Plc’s remuneration policy to protest a “golden hello” payment and planned incentives for Chief Executive Officer Pascal Soriot.
-
A remote mine in northern Brazil is set to produce gold so cheaply that its Australian owner Beadell Resources Ltd. could prove irresistible to a buyer.
-
AstraZeneca Plc will cut about 1,600 jobs as it overhauls research and development, leading to $1.4 billion in costs as new Chief Executive Officer Pascal Soriot tries to revive the U.K.’s second-biggest drugmaker.
-
AstraZeneca Plc plans to cut 2,300 sales and administrative jobs and narrow its drug-research focus in a bid to return to earnings growth as patents on its best- selling medicines expire.
-
David Brennan couldn’t sit still. During a meal of beef and potatoes at AstraZeneca Plc’s drug research center near Stockholm in October, Brennan, the company’s chief executive officer, grilled six drug-development managers over a concern raised by a laboratory scientist.
-
AstraZeneca Plc Chief Executive Officer David Brennan will retire from his post, ending a six- year tenure after repeated failures in drug development left investors skeptical of the company’s earnings prospects.
-
AstraZeneca Plc suspended share buybacks as the board and new Chief Executive Officer Pascal Soriot review strategy at the U.K. drugmaker, prompting renewed speculation that the company will embark on larger takeovers.
-
AstraZeneca Plc forecast profit this year will decline “significantly more than revenue” as the U.K.’s second-biggest drugmaker faces increasing competition from lower-priced generic medicines.
-
David Brennan said his leadership as chief executive officer of London-based drugmaker AstraZeneca Plc remains steady amid reports that some shareholders are seeking a change.
-
AstraZeneca Plc , the U.K.’s second- largest drugmaker, is scaling up its up its operations in South Africa, where sales are growing faster than in more established markets, Chief Executive Officer David Brennan said.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page